Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review
Grace E Fox,1 Mark Bernauer,1 Jennifer M Stephens,1 Bianca Jackson,1 Joshua A Roth,2 Ahmed Shelbaya2,3 1Strategic Market Access, OPEN Health, Bethesda, MD, USA; 2Global Access and Value, Pfizer Inc., New York, NY, USA; 3Department of Epidemiology, Mailman School of Public Health, Columbia University...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2024-05-01
|
| Serie: | ClinicoEconomics and Outcomes Research |
| Soggetti: | |
| Accesso online: | https://www.dovepress.com/clinical-and-economic-value-of-a-biosimilar-portfolio-to-stakeholders--peer-reviewed-fulltext-article-CEOR |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|